Evidence map›Paper›PMID 31317345›Full record

ArticleDrug delivery and translational research2019

Accelerated and scarless wound repair by a multicomponent hydrogel through simultaneous activation of multiple pathways.

Dipsikha Bhattacharya, Ratnakar Tiwari, Tejasvi Bhatia, Mahaveer Prasad Purohit, Anu Pal, Pankaj Jagdale, Mohana Krishna Reddy Mudiam, Bhushan Pradosh Chaudhari, Yogeshwar Shukla, Kausar Mahmood Ansari and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. CeOPolymers · 2021
    Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Dipsikha BhattacharyaCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Ratnakar TiwariCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Tejasvi BhatiaCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Mahaveer Prasad PurohitCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Anu PalCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Pankaj JagdaleCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Mohana Krishna Reddy MudiamCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Bhushan Pradosh ChaudhariCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Yogeshwar ShuklaCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Kausar Mahmood AnsariCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India.
Ashok KumarDepartment of Biological Sciences and Bioengineering (BSBE) and Centre for Environmental Science and Engineering (CESE), Indian Institute of Technology, Kalyanpur, Kanpur, Uttar Pradesh, 208016, India.
Pradeep KumarCSIR-Institute of Genomics and Integrative Biology, Delhi University Campus, Mall Road, Delhi, 110007, India.
Vikas SrivastavaCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India. 76.vikas@gmail.com.
Kailash Chand GuptaCSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31 Mahatma Gandhi Marg, P.O. Box No. 80, Lucknow, Uttar Pradesh, 226 001, India. kcgupta@igib.res.in.
Indian Institute of Toxicology Research · INAcademy of Scientific and Innovative Research · INIndian Institute of Technology Kanpur · INAdamas University · INUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scarless healing of injury remains a clinical challenge because of its complicated and overlapping phases of inflammation, clearing, and regeneration. Curcumin has been already established as a potential wound healing agent for normal and diabetic-impaired wounds. Herein, the question has been addressed whether a well-known antioxidant cerium oxide nanoparticle (CNP) can potentiate the activity of curcumin to promote a cellular program for scarless healing. In this study, we have developed a biocompatible poly (acrylamide) hydrogel (PAGE)-based dressing material comprising of CNP and curcumin (ACC) and tested its wound healing activity in an animal model of acute wound. Characterization of the CNP- and curcumin-entrapped hydrogel dressing (ACC) demonstrated high loading efficiency and sustained release of curcumin. In a full-thickness acute wound healing model of rat, a single application of ACC dressing demonstrated higher wound healing efficacy (78%) and negligible scarring compared to dressings containing only curcumin or CNP in 7 days. Enhanced cell proliferation, higher collagen content, advanced wound maturity, re-epithelialization, and granulation tissue formation were observed using the combination of curcumin and CNP (ACC). Study of cellular mechanisms identified MCP-1 and TGF-β as the key drivers of differential and accelerated healing observed in the ACC group. These, coupled with the upregulation of growth-related signaling pathways (HER2/ErbB2, TGF-β-Smad2/3, MAPK/ERK, AKT, and VEGF), promoted almost scarless healing in animals treated with ACC. The optimized combination of curcumin and CNP used in our study shows distinct advantage and can be a better agent for complete wound healing.

Indexed as

AnimalsCell LineCeriumCurcuminCytokinesDrug CarriersDrug LiberationHumansHydrogelsMaleNanoparticlesProtein KinasesRats, WistarSkinWound Healingceric oxideCeriumCurcuminCytokinesDrug CarriersHydrogelsProtein KinasesAnti-inflammatoryAntioxidantCerium oxide nanoparticlesCurcuminWound healing

Identifiers

PMID31317345
OpenAlexW2957521742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.